Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor
Mark S. Gresnigt(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Oumaïma Ibrahim-Granet(Institut Pasteur), Matthias Brock(University of Nottingham), Éric Dannaoui(Hôpital Necker-Enfants Malades), Abdessalem Rekiki(Institut Pasteur), Catherine Fitting(Institut Pasteur), Amélie Savers(University of Nottingham), Grégory Jouvion(Institut Pasteur), Frank L. van de Veerdonk(Radboud University Nijmegen), Marianna Parlato(Université Paris Cité), Jean-Marc Cavaillon(Institut Pasteur), Orhan Raşid(Institutul Cantacuzino)
Cited by 44
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome
|Circulation|2002|1k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Dysregulation of in vitro cytokine production by monocytes during sepsis.
|Journal of Clinical Investigation|1991|765